From October 1, 2023 to December 31, 2023, the company has repurchased 20,000 shares, representing 0.02% for CNY 1.07 million. With this, the company has completed the repurchase of 29,829 shares, representing 0.02% for CNY 1.59 million under the buyback announced on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58.02 CNY | -0.99% | -3.83% | -9.03% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.03% | 97Cr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.